trending Market Intelligence /marketintelligence/en/news-insights/trending/FNjV_G_RQIri5Eag1EOsbQ2 content esgSubNav
In This List

XTL Biopharmaceuticals CFO to step down

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


XTL Biopharmaceuticals CFO to step down

David Kestenbaum plans to cease his services as CFO of XTL Biopharmaceuticals Ltd. and pursue other opportunities.

Kestenbaum will continue working during his notice period, and his successor will be announced in due course.